Orserdu (Elacestrant): Uses, Side Effects & Interactions
1. Introduction And Mechanism Of Action Of Orserdu Orserdu containing the active ingredient elacestrant is an oral selective estrogen receptor degrader indicated for advanced or metastatic breast cancer with specific genetic mutations. The most prominent adverse effects include significant musculoskeletal pain, nausea, and clinically elevated lipid profiles. This targeted oncological therapy provides a systemic intervention … Read more